This Tiny Brain Implant Could Treat Depression at Home
The early feasibility study will enroll adults with treatment-resistant depression and measure safety, device performance, and early effectiveness.
7 Articles
7 Articles
FDA clears first US trial of brain implant for severe depression
A tiny brain implant, no bigger than a blueberry, is moving from lab concept to human testing in the United States. Motif Neurotech has secured clearance from the U.S. Food and Drug Administration to begin its first clinical trial targeting treatment-resistant depression. The decision marks a key step for a company aiming to bring engineering-driven solutions into mainstream mental health care. Nearly 3 million Americans live with forms of depre…
The United States has authorized the first clinical trial of a wireless brain implant to treat depression that does not lend itself to standard therapy. The device will be tested on adult patients who have not been helped by other treatments.
FDA authorizes tests of brain implant against depression - Root-Nation.com
A small brain implant no bigger than a blueberry is finally leaving the lab. Motif Neurotech has received official permission from the FDA to conduct the first human clinical trial of its device. The target audience is patients with resistant depression that cannot be overcome by conventional methods. In fact, this is a huge step […] Post A breakthrough in medicine: FDA authorizes trial of brain implant against depression at Root-Nation.com.
A Brain Implant for Depression Is About to Be Tested in Humans
(Wired) – While many brain-computer interface companies are focused on helping paralyzed people communicate, Motif Neurotech is targeting mental health disorders. The latest brain-computer interface could help people recover from severe depression. Motif Neurotech announced Monday that the US Food and Drug Administration has approved a human study to trial the company’s blueberry-sized brain implant that sits in the skull and delivers electrical…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium





